Bardin Hill Management Partners LP Aurinia Pharmaceuticals Inc. Transaction History
Bardin Hill Management Partners LP
- $198 Million
- Q4 2024
A detailed history of Bardin Hill Management Partners LP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Bardin Hill Management Partners LP holds 158 shares of AUPH stock, worth $1,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
158Holding current value
$1,333% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AUPH
# of Institutions
227Shares Held
58.9MCall Options Held
949KPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$78.3 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$71.1 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$54 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$33.5 Million2.55% of portfolio
-
State Street Corp Boston, MA2.92MShares$24.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.2B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...